Dr. K R Balakrishnan, Director, Cardiac Sciences, Fortis Centre for Heart Failure and Transplant, at Fortis Malar, said, “The majority of patients who can benefit from our advanced therapy are not aware of the facilities available in India. Moreover, in Tamil Nadu alone, each year, 100-150 organ donors are available but the heart transplants carried out are around 20. Our goal is to provide the highest quality of patient-centered care to many more patients, right here in India, utilizing our interdisciplinary approach, enormous talent and the multi-skilled resources within our team.”
Heart Failure is a major health concern worldwide including in India. Twenty million people world-wide suffer from heart failure, out of which India witnesses two million new cases every year with at least a third of them requiring advanced therapy to survive. It is also important to note that, the mortality in heart failure patients is as high as 30-40%, within a year of diagnosis. In India, the treatment for heart failure is restricted to medical therapy, revascularization therapy (restoration/augmentation of blood supply to the heart), valvular surgeries and cardiac resynchronization (heart pacing) therapy.
With copious and wide ranging experience in handling heart failure patients including the implanting of India’s first artificial heart, Fortis Malar Hospital is recognized all over the world today as a centre of excellence providing the latest technology in heart care.
